Catalyst Biosciences, Inc. - Product Pipeline Review – 2015 Now Available at iData Insights Catalyst Biosciences, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct s, Catalyst Biosciences, Inc. - Product Pipeline Review - 2015 , provides an overview of the Catalyst Biosciences, Inc. s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Catalyst Biosciences, Inc. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Catalyst Biosciences, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Catalyst Biosciences, Inc. s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Catalyst Biosciences, Inc. s pipeline products Reasons to buy - Evaluate Catalyst Biosciences, Inc. s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Catalyst Biosciences, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Catalyst Biosciences, Inc. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Catalyst Biosciences, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Catalyst Biosciences, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Catalyst Biosciences, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landing-page.php?id=124205/catalystbiosciences-inc-product-pipeline-review-2015 To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landing-page.php?id=124205/catalystbiosciences-inc-product-pipeline-review-2015 Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Catalyst Biosciences, Inc. Snapshot 5 Catalyst Biosciences, Inc. Overview 5 Key Information 5 Key Facts
1
5 Catalyst Biosciences, Inc.
Research and Development Overview
6 Key Therapeutic Areas 6 Catalyst Biosciences, Inc. 8 Pipeline Products
Pipeline Review 8 Pipeline Products by Stage of Development
Monotherapy
9 Catalyst Biosciences, Inc. 10 Catalyst Biosciences, Inc.
Pipeline Products Glance Clinical Stage Pipeline Products
10 Phase I Products/Combination Treatment Modalities 10 Catalyst Biosciences, Inc.
Early Stage Pipeline Products
11 Preclinical Products/Combination Treatment Modalities 11 Discovery Products/Combination Treatment Modalities 12 Catalyst Biosciences, Inc.
Drug Profiles
13 CB-813d 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 CB-2679d 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 CB-2782 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 CB-FXa 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Small Molecules to Agonize Neuronal Nicotinic Acetylcholine Receptor for Smoking Cessation 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 TC-7020 19 Product Description 19 Mechanism of Action
2
19 R&D Progress 19 TC-8831 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Recombinant Enzymes to Inhibit Complement C3 for Dry Age-Related Macular Degeneration 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Small Molecule for Central Nervous System Disorders 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Catalyst Biosciences, Inc.
Pipeline Analysis
23 Catalyst Biosciences, Inc.
Pipeline Products by Target
23 Catalyst Biosciences, Inc.
Pipeline Products by Route of Administration
24 Catalyst Biosciences, Inc.
Pipeline Products by Molecule Type
25 Catalyst Biosciences, Inc.
Pipeline Products by Mechanism of Action
26 Catalyst Biosciences, Inc.
Recent Pipeline Updates
27 Catalyst Biosciences, Inc.
Dormant Projects
31 Catalyst Biosciences, Inc.
Discontinued Pipeline Products
32 Discontinued Pipeline Product Profiles 32 bradanicline 32 dexmecamylamine 32 ispronicline 32 TC-2216 32 TC-2696 33 TC-6499 33 TC-6683 33 Catalyst Biosciences, Inc.
Locations And Subsidiaries
34 Head Office 34 Appendix 35 Methodology 35 Coverage
3
35 Secondary Research 35 Primary Research 35 Expert Panel Validation 35 Contact Us 35 Disclaimer Read More @ http://www.idatainsights.com/reports-landing-page.php?id=124205/catalyst-biosciences-inc-productpipeline-review-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.
Contact Us: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com
About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects.
4